January/February 2013 - Volume 36 - Issue 1
pp: 1-35

Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease

Burstein, Aaron H.; Zhao, Qinying; Ross, Joel; More

Clinical Neuropharmacology. 36(1):8-13, January/February 2013.

Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease: A Phase I, Randomized, Placebo-Controlled, Double-Blind,...

Landen, Jaren W.; Zhao, Qinying; Cohen, Sharon; More

Clinical Neuropharmacology. 36(1):14-23, January/February 2013.